112 related articles for article (PubMed ID: 1901830)
1. The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.
James RF; Edwards S; Hui KM; Bassett PD; Grosveld F
Immunology; 1991 Feb; 72(2):213-8. PubMed ID: 1901830
[TBL] [Abstract][Full Text] [Related]
2. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
Hui KM; Sim T; Foo TT; Oei AA
J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
[TBL] [Abstract][Full Text] [Related]
3. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
5. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-gamma.
Green WR; Phillips JD
J Immunol; 1986 Aug; 137(3):814-8. PubMed ID: 3088110
[TBL] [Abstract][Full Text] [Related]
7. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
Green WR
J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
[TBL] [Abstract][Full Text] [Related]
8. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
9. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
10. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
11. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
[TBL] [Abstract][Full Text] [Related]
12. Target cell expression of MHC antigens is not (always) a turn-off signal to natural killer cells.
Chervenak R; Wolcott RM
J Immunol; 1988 Jun; 140(11):3712-6. PubMed ID: 3259596
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cells.
Bahler DW; Cerosaletti KM; Lord EM; Frelinger JG
J Immunol; 1988 Jun; 140(11):4003-12. PubMed ID: 2453562
[TBL] [Abstract][Full Text] [Related]
14. The influence of self-MHC and non-MHC antigens on the selection of an antigen-specific T cell receptor repertoire.
Fry AM; Cotterman MM; Matis LA
J Immunol; 1989 Oct; 143(8):2723-9. PubMed ID: 2477456
[TBL] [Abstract][Full Text] [Related]
15. Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.
Hui K; Grosveld F; Festenstein H
Nature; 1984 Oct 25-31; 311(5988):750-2. PubMed ID: 6333639
[TBL] [Abstract][Full Text] [Related]
16. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
18. Rejection of mouse sarcoma cells after transfection of MHC class II genes.
Ostrand-Rosenberg S; Thakur A; Clements V
J Immunol; 1990 May; 144(10):4068-71. PubMed ID: 2332639
[TBL] [Abstract][Full Text] [Related]
19. Association between MHC class I antigen expression and malignancy of murine T lymphoma variants.
Vanden Driessche T; Verschueren H; De Baetselier P
Invasion Metastasis; 1990; 10(2):65-85. PubMed ID: 2307562
[TBL] [Abstract][Full Text] [Related]
20. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]